Katrin Mehler1, André Oberthür2, Ayla Yagdiran3, Sarina Butzer2, Norma Jung4. 1. Department of Pediatrics, Faculty of Medicine, University Hospital of Cologne, Kerpenerstr. 62, 50397, Cologne, Germany. Katrin.Mehler@uk-koeln.de. 2. Department of Pediatrics, Faculty of Medicine, University Hospital of Cologne, Kerpenerstr. 62, 50397, Cologne, Germany. 3. Department of Orthopedics and Trauma Surgery, University Hospital of Cologne, Cologne, Germany. 4. Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Abstract
PURPOSE: In recent years an earlier step down to oral antibiotic therapy has been advocated for numerous infections. Trained infectious disease specialists regularly consulting their colleagues may speed up the implementation of such recommendations into clinical practice and thus may improve treatment. METHODS: We retrospectively analyzed bone and joint infections in children admitted to the University Hospital of Cologne between 2010 and 2021. We assessed clinical, imaging, and microbiological findings and treatment modalities. Additionally, we assessed both the impact of a newly implemented pediatric infectious diseases consultation service and publications on revised treatment recommendations by comparing antibiotic therapy in two periods (2010-2016 versus 2017 to 2021). RESULTS: In total, 29 children presented with osteomyelitis, 16 with bacterial arthritis and 7 with discitis. In period 2 (2017-2021) we observed shorter duration of intravenous treatment (p = 0.009) and a higher percentage of oral antibiotic treatment in relation to the total duration of antibiotics (25% versus 59%, p = 0.007) compared to period 1 (2010-2016). Yet, no differences were identified for the total length of antibiotic treatment. Additionally, biopsies or synovial fluid samples were retrieved and cultured in more children in period 2 (p = 0.077). The main pathogen identified in osteomyelitis and bacterial arthritis was Staphylococcus aureus (MSSA), diagnosis was confirmed predominantly with MRI. CONCLUSION: Recent guidelines addressing the safety of an earlier step-down (to oral) antibiotic therapy have influenced clinical practice in the treatment of bone and joint infections in our hospital. A newly implemented pediatric infectious diseases consultation service might have accelerated this progress resulting in a faster step down to oral treatment.
PURPOSE: In recent years an earlier step down to oral antibiotic therapy has been advocated for numerous infections. Trained infectious disease specialists regularly consulting their colleagues may speed up the implementation of such recommendations into clinical practice and thus may improve treatment. METHODS: We retrospectively analyzed bone and joint infections in children admitted to the University Hospital of Cologne between 2010 and 2021. We assessed clinical, imaging, and microbiological findings and treatment modalities. Additionally, we assessed both the impact of a newly implemented pediatric infectious diseases consultation service and publications on revised treatment recommendations by comparing antibiotic therapy in two periods (2010-2016 versus 2017 to 2021). RESULTS: In total, 29 children presented with osteomyelitis, 16 with bacterial arthritis and 7 with discitis. In period 2 (2017-2021) we observed shorter duration of intravenous treatment (p = 0.009) and a higher percentage of oral antibiotic treatment in relation to the total duration of antibiotics (25% versus 59%, p = 0.007) compared to period 1 (2010-2016). Yet, no differences were identified for the total length of antibiotic treatment. Additionally, biopsies or synovial fluid samples were retrieved and cultured in more children in period 2 (p = 0.077). The main pathogen identified in osteomyelitis and bacterial arthritis was Staphylococcus aureus (MSSA), diagnosis was confirmed predominantly with MRI. CONCLUSION: Recent guidelines addressing the safety of an earlier step-down (to oral) antibiotic therapy have influenced clinical practice in the treatment of bone and joint infections in our hospital. A newly implemented pediatric infectious diseases consultation service might have accelerated this progress resulting in a faster step down to oral treatment.
Authors: Brendan J McMullan; David Andresen; Christopher C Blyth; Minyon L Avent; Asha C Bowen; Philip N Britton; Julia E Clark; Celia M Cooper; Nigel Curtis; Emma Goeman; Briony Hazelton; Gabrielle M Haeusler; Ameneh Khatami; James P Newcombe; Joshua Osowicki; Pamela Palasanthiran; Mike Starr; Tony Lai; Clare Nourse; Joshua R Francis; David Isaacs; Penelope A Bryant Journal: Lancet Infect Dis Date: 2016-06-16 Impact factor: 25.071
Authors: Katharina Kreitmeyr; Ulrich von Both; Alenka Pecar; Johannes P Borde; Rafael Mikolajczyk; Johannes Huebner Journal: Infection Date: 2017-04-10 Impact factor: 3.553
Authors: Robert Tracy Ballock; Peter O Newton; Sean J Evans; Michelle Estabrook; Christine L Farnsworth; John S Bradley Journal: J Pediatr Orthop Date: 2009-09 Impact factor: 2.324
Authors: Amanda Gwee; Jonathan R Carapetis; Jim Buttery; Mike Starr; Tom G Connell; Andrew Steer; Penelope A Bryant; Nigel Curtis Journal: Pediatr Infect Dis J Date: 2014-04 Impact factor: 2.129
Authors: Charles R Woods; John S Bradley; Archana Chatterjee; Lawson A Copley; Joan Robinson; Matthew P Kronman; Antonio Arrieta; Sandra L Fowler; Christopher Harrison; Maria A Carrillo-Marquez; Sandra R Arnold; Stephen C Eppes; Laura P Stadler; Coburn H Allen; Lynnette J Mazur; C Buddy Creech; Samir S Shah; Theoklis Zaoutis; David S Feldman; Valéry Lavergne Journal: J Pediatric Infect Dis Soc Date: 2021-09-23 Impact factor: 3.164